# FDA Warning Letter: OsteoLife Biomedical I LLC
> 2022-05-31 · Office of Biological Products Operations – Division I · `3a6e2aa9e3bc9cdb`
## Letter
- **Company:** OsteoLife Biomedical I LLC
- **Posted Date:** 2022-05-31
- **Letter Issue Date:** 2022-03-31
- **Issuing Office:** Office of Biological Products Operations – Division I
## Subject
Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*